{"id":81452,"date":"2021-02-07T05:52:18","date_gmt":"2021-02-07T05:52:18","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=81452"},"modified":"2021-02-07T05:52:18","modified_gmt":"2021-02-07T05:52:18","slug":"me-too-drug","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/me-too-drug\/","title":{"rendered":"Me too drug"},"content":{"rendered":"

A drug that is identical, similar, or closely related to a drug product for which a new drug application has been approved, Many ‘me too’ drugs on the market are essentially copies of approved new drug but were introduced by the manufacturers without Food and Drug Administration approval on the theory that the NDA holder, or pioneer drug, had become generally recognized as safe and effective. Other ‘me too’ products are being marketed with abbreviated new drug applications (ANDAs), which require the submission of manufacturing, bioavailability and labeling information, but not data relating to safety and effectiveness, which are assumed to be established.<\/p>\n

\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

A drug that is identical, similar, or closely related to a drug product for which a new drug application has been approved, Many ‘me too’ drugs on the market are essentially copies of approved new drug but were introduced by the manufacturers without Food and Drug Administration approval on the theory that the NDA holder, […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["post-81452","post","type-post","status-publish","format-standard","hentry","category-m"],"yoast_head":"\nMe too drug - Definition of Me too drug<\/title>\n<meta name=\"description\" content=\"A drug that is identical, similar, or closely related to a drug product for which a new drug application has been approved, Many 'me too' drugs on the market are essentially copies of approved new drug but were introduced by the manufacturers without Food and Drug Administration approval on the theory that the NDA holder, or pioneer drug, had become generally recognized as safe and effective. Other 'me too' products are being marketed with abbreviated new drug applications (ANDAs), which require the submission of manufacturing, bioavailability and labeling information, but not data relating to safety and effectiveness, which are assumed to be established.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/me-too-drug\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Me too drug - Definition of Me too drug\" \/>\n<meta property=\"og:description\" content=\"A drug that is identical, similar, or closely related to a drug product for which a new drug application has been approved, Many 'me too' drugs on the market are essentially copies of approved new drug but were introduced by the manufacturers without Food and Drug Administration approval on the theory that the NDA holder, or pioneer drug, had become generally recognized as safe and effective. Other 'me too' products are being marketed with abbreviated new drug applications (ANDAs), which require the submission of manufacturing, bioavailability and labeling information, but not data relating to safety and effectiveness, which are assumed to be established.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/me-too-drug\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-07T05:52:18+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/me-too-drug\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/me-too-drug\/\",\"name\":\"Me too drug - Definition of Me too drug\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2021-02-07T05:52:18+00:00\",\"dateModified\":\"2021-02-07T05:52:18+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"A drug that is identical, similar, or closely related to a drug product for which a new drug application has been approved, Many 'me too' drugs on the market are essentially copies of approved new drug but were introduced by the manufacturers without Food and Drug Administration approval on the theory that the NDA holder, or pioneer drug, had become generally recognized as safe and effective. Other 'me too' products are being marketed with abbreviated new drug applications (ANDAs), which require the submission of manufacturing, bioavailability and labeling information, but not data relating to safety and effectiveness, which are assumed to be established.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/me-too-drug\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/me-too-drug\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/me-too-drug\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Me too drug\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Me too drug - Definition of Me too drug","description":"A drug that is identical, similar, or closely related to a drug product for which a new drug application has been approved, Many 'me too' drugs on the market are essentially copies of approved new drug but were introduced by the manufacturers without Food and Drug Administration approval on the theory that the NDA holder, or pioneer drug, had become generally recognized as safe and effective. Other 'me too' products are being marketed with abbreviated new drug applications (ANDAs), which require the submission of manufacturing, bioavailability and labeling information, but not data relating to safety and effectiveness, which are assumed to be established.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/me-too-drug\/","og_locale":"en_US","og_type":"article","og_title":"Me too drug - Definition of Me too drug","og_description":"A drug that is identical, similar, or closely related to a drug product for which a new drug application has been approved, Many 'me too' drugs on the market are essentially copies of approved new drug but were introduced by the manufacturers without Food and Drug Administration approval on the theory that the NDA holder, or pioneer drug, had become generally recognized as safe and effective. Other 'me too' products are being marketed with abbreviated new drug applications (ANDAs), which require the submission of manufacturing, bioavailability and labeling information, but not data relating to safety and effectiveness, which are assumed to be established.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/me-too-drug\/","og_site_name":"Glossary","article_published_time":"2021-02-07T05:52:18+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/me-too-drug\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/me-too-drug\/","name":"Me too drug - Definition of Me too drug","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2021-02-07T05:52:18+00:00","dateModified":"2021-02-07T05:52:18+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"A drug that is identical, similar, or closely related to a drug product for which a new drug application has been approved, Many 'me too' drugs on the market are essentially copies of approved new drug but were introduced by the manufacturers without Food and Drug Administration approval on the theory that the NDA holder, or pioneer drug, had become generally recognized as safe and effective. Other 'me too' products are being marketed with abbreviated new drug applications (ANDAs), which require the submission of manufacturing, bioavailability and labeling information, but not data relating to safety and effectiveness, which are assumed to be established.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/me-too-drug\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/me-too-drug\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/me-too-drug\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Me too drug"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/81452","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=81452"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/81452\/revisions"}],"predecessor-version":[{"id":81453,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/81452\/revisions\/81453"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=81452"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=81452"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=81452"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}